February 7th, 2026
Description
Breast cancer is well researched enabling cure rates to be maximized and side effects controlled for the majority of women and despite several subtypes and sometimes aggressive forms of the disease. The annual San Antonio Breast Cancer Symposium (SABCS) is shaped by a group of highly experienced and expert planners who survey various topics and clinical trials to determine what is salient to practicing clinicians. Of note, our planning group reviews the preliminary SABCS program, reflects on and discusses their clinical practices, and maturing clinical trials in preparing our SABCS Review agenda.
For pricing information, see pricing tab below.
Dates and Times
Start: 2/7/2026 8:00 AM
End: 2/7/2026 2:25 PM
Objectives
- Articulate the current best practices for surgical management of breast cancer
- Define how recent evidence impacts management of hormone receptor positive breast cancer
- Describe the optimal management of HER2+ breast cancer
- Explain what recent evidence teaches about radiation therapy for breast cancer
- Identify the current best practices for treating triple negative breast cancer
- Characterize the evidence behind supportive care for breast cancer patients
Agenda
7:55 am Welcome Remarks
8:00 am Current Best Practices in the Surgical Management of Breast
Cancer (Dr Morgan Jones)
8:35 am Targeting Treatment Resistance in Estrogen-Positive Breast
Cancer (Dr Dionisia Quiroga)
9:10 am Recent Advances in the Management of HER2-Positive Breast
Cancer (Dr Ada Walks)
9:45 am Mid-morning Break
10:00 am Expert Use of Radiation Therapy in Breast Cancer (Dr Erin Healy)
10:35 pm What You Need to Know About Supportive Oncology (Dr Ashley
Davenport)
11:10 am Ask the Expert Panel: Evaluation and Management of Patients at
High Risk for Breast Cancer (Moderator: Dr Sagar Sardesai)
11:50 am Lunch
12:10 am Breakout Sessions:
Multidisciplinary Management of Young Adults with Breast Cancer
(Drs Sara Myers, Sachin Jhawar, and Nerea Lia)
Evolving Role of Antibody Drug Congregates (ADCs) in the Management of Breast Cancer (Dr Robert Wesolowski and Dr Gilbert Bader)
What To Do Next After Progression on 1st Line Endocrine Therapy in Hormone Positive Metastatic Breast Cancer (Dr Margaret Gatti-Mays and Dr Arya Roy)
1:10 pm Emerging Trends in the Management of Triple Negative Breast
Cancer (Dr Roberto Leone-Ferre)
1:45 pm Ask the Expert Panel: Case-Based Discussion of Dilemmas in
Breast Cancer (Dr Daniel Stover)
2:25 pm Closing Remarks, Evaluations and Adjourn
Pricing
| Tier | Price |
|---|---|
| RN | $40.00 |
| APP | $65.00 |
| MD and DO | $150.00 |
| Other Healthcare Professional | $40.00 |
| Residents, Fellow, and Advocates | $0.00 |
Location
Marriott Columbus OSU
3100 Olentangy River Rd.
Columbus, OH 43202
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.